Literature DB >> 11767404

Interactions of nitric oxide-derived reactive nitrogen species with peroxidases and lipoxygenases.

M J Coffey1, B Coles, V B O'Donnell.   

Abstract

Nitric oxide (NO) is a major free radical modulator of smooth muscle tone, which under basal conditions acts to preserve vascular homeostasis through its anti-inflammatory properties. The biochemistry of NO, in particular, its rapid conversion in vivo into secondary reactive nitrogen species (RNS), its chemical nature as a free radical and its high diffusibility and hydrophobicity dictate that this species will interact with numerous biomolecules and enzymes. In this review, we consider the interactions of a number of enzymes found in the vasculature with NO and NO-derived RNS. All these enzymes are either homeostatic or promote the development of atherosclerosis and hypertension. Therefore their interactions with NO and NO-derived RNS will be of central importance in the initiation and progression of vascular disease. In some examples, (e.g. lipoxygenase, LOX), such interactions provide catalytic 'sinks' for NO, but for others, in particular peroxidases and prostaglandin H synthase (PGHS), reactions with NO may be detrimental. Nitric oxide and NO-derived RNS directly modulate the activity of vascular peroxidases and LOXs through a combination of effects, including transcriptional regulation, altering substrate availability, and direct reaction with enzyme turnover intermediates. Therefore, these interactions will have two major consequences: (i) depletion of NO levels available to cause vasorelaxation and prevent leukocyte/platelet adhesion and (ii) modulation of activity of the target enzymes, thereby altering the generation of bioactive signaling molecules involved in maintenance of vascular homeostasis, including prostaglandins and leukotrienes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11767404     DOI: 10.1080/10715760100301471

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  6 in total

Review 1.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

2.  Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors.

Authors:  Peter B Anning; Barbara Coles; Jonathan Morton; Haibin Wang; Jashim Uddin; Jason D Morrow; Sudhansu K Dey; Lawrence J Marnett; Valerie B O'Donnell
Journal:  Blood       Date:  2006-08-24       Impact factor: 22.113

Review 3.  Redox homeostasis in mycobacteria: the key to tuberculosis control?

Authors:  Ashwani Kumar; Aisha Farhana; Loni Guidry; Vikram Saini; Mary Hondalus; Adrie J C Steyn
Journal:  Expert Rev Mol Med       Date:  2011-12-16       Impact factor: 5.600

4.  Enhanced anti-inflammatory potency of a nitric oxide-releasing prednisolone derivative in the rat.

Authors:  Fusun Turesin; Piero del Soldato; John L Wallace
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

5.  Specific mediator inhibition by the NO donors SNP and NCX 2057 in the peripheral lung: implications for allergen-induced bronchoconstriction.

Authors:  Anna-Karin Larsson; Magnus Bäck; Jon O Lundberg; Sven-Erik Dahlén
Journal:  Respir Res       Date:  2009-06-04

6.  Inhibition of pacemaker activity in interstitial cells of Cajal by LPS via NF-κB and MAP kinase.

Authors:  Dong Chuan Zuo; Seok Choi; Pawan Kumar Shahi; Man Yoo Kim; Chan Guk Park; Young Dae Kim; Jun Lee; In Yeoup Chang; Insuk So; Jae Yeoul Jun
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.